PT101007A - Preparado liofilizado e estavel de icrf-187 e seu uso e processo de preparacao de liofilizado de icrf-187 - Google Patents
Preparado liofilizado e estavel de icrf-187 e seu uso e processo de preparacao de liofilizado de icrf-187Info
- Publication number
- PT101007A PT101007A PT101007A PT10100792A PT101007A PT 101007 A PT101007 A PT 101007A PT 101007 A PT101007 A PT 101007A PT 10100792 A PT10100792 A PT 10100792A PT 101007 A PT101007 A PT 101007A
- Authority
- PT
- Portugal
- Prior art keywords
- icrf
- lyophilized
- preparation process
- stably prepared
- hours
- Prior art date
Links
- BMKDZUISNHGIBY-ZETCQYMHSA-N (+)-dexrazoxane Chemical compound C([C@H](C)N1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 BMKDZUISNHGIBY-ZETCQYMHSA-N 0.000 title abstract 5
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 230000002939 deleterious effect Effects 0.000 abstract 1
- 238000012792 lyophilization process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919122720A GB9122720D0 (en) | 1991-10-25 | 1991-10-25 | (s)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)formulations and their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT101007A true PT101007A (pt) | 1994-01-31 |
| PT101007B PT101007B (pt) | 1999-07-30 |
Family
ID=10703550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT101007A PT101007B (pt) | 1991-10-25 | 1992-10-23 | Preparado liofilizado e estavel de icrf-187 e seu uso e processo de preparacao de liofilizado de icrf-187 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0619735B1 (pt) |
| AT (1) | ATE193205T1 (pt) |
| AU (1) | AU2791292A (pt) |
| DE (1) | DE69231098T2 (pt) |
| DK (1) | DK0619735T3 (pt) |
| ES (1) | ES2145748T3 (pt) |
| GB (1) | GB9122720D0 (pt) |
| GR (1) | GR3034135T3 (pt) |
| MX (1) | MX9206139A (pt) |
| PT (1) | PT101007B (pt) |
| WO (1) | WO1993007873A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265385B1 (en) * | 1996-01-11 | 2001-07-24 | Topo Target Aps | Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy |
| BR0009473A (pt) | 1999-03-12 | 2001-11-27 | Antianthra Aps | Tratamento de extravasamento acidental deantraciclinas |
| WO2007062076A2 (en) * | 2005-11-23 | 2007-05-31 | Novartis Ag | Dexrazoxane formulations and methods |
| CN114306251B (zh) * | 2021-12-22 | 2023-08-11 | 乐普药业股份有限公司 | 一种含有右雷佐生的冻干制剂及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1234935A (en) * | 1967-07-03 | 1971-06-09 | Nat Res Dev | Piperazine derivatives |
| US4963551A (en) * | 1987-12-21 | 1990-10-16 | Erbamont Inc. | Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof |
-
1991
- 1991-10-25 GB GB919122720A patent/GB9122720D0/en active Pending
-
1992
- 1992-10-22 ES ES92921457T patent/ES2145748T3/es not_active Expired - Lifetime
- 1992-10-22 EP EP92921457A patent/EP0619735B1/en not_active Expired - Lifetime
- 1992-10-22 DE DE69231098T patent/DE69231098T2/de not_active Expired - Lifetime
- 1992-10-22 WO PCT/EP1992/002400 patent/WO1993007873A1/en not_active Ceased
- 1992-10-22 AU AU27912/92A patent/AU2791292A/en not_active Abandoned
- 1992-10-22 AT AT92921457T patent/ATE193205T1/de active
- 1992-10-22 DK DK92921457T patent/DK0619735T3/da active
- 1992-10-23 MX MX9206139A patent/MX9206139A/es unknown
- 1992-10-23 PT PT101007A patent/PT101007B/pt not_active IP Right Cessation
-
2000
- 2000-08-07 GR GR20000401830T patent/GR3034135T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3034135T3 (en) | 2000-11-30 |
| DE69231098T2 (de) | 2000-09-14 |
| AU2791292A (en) | 1993-05-21 |
| ATE193205T1 (de) | 2000-06-15 |
| DE69231098D1 (de) | 2000-06-29 |
| ES2145748T3 (es) | 2000-07-16 |
| DK0619735T3 (da) | 2000-12-04 |
| WO1993007873A1 (en) | 1993-04-29 |
| GB9122720D0 (en) | 1991-12-11 |
| EP0619735B1 (en) | 2000-05-24 |
| PT101007B (pt) | 1999-07-30 |
| MX9206139A (es) | 1993-07-01 |
| EP0619735A1 (en) | 1994-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI61807B (fi) | Foerfarande foer stabilisering av meningokockpolysackarid | |
| KR930007453A (ko) | 동결건조 이포스파미드 조성물 | |
| DE69632669D1 (de) | Salz-stabilisierte Enzymzubereitung | |
| FI890508A0 (fi) | Menetelmä farmaseuttisesti aktiivisten 3-indolipalorypälehappojohdannaisten valmistamiseksi | |
| GR3006172T3 (pt) | ||
| ATE148165T1 (de) | Stabilisierung von hochgereinigten proteinen | |
| ES2143132T3 (es) | Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion. | |
| JPS559023A (en) | Production of dopa preparation in high concentration | |
| JPS54147916A (en) | Preparation of urokinase injection | |
| US4079126A (en) | Method of preparing a component consisting of sugar, lipid and protein derived from Pseudomonas aeruginosa which possess anti-tumor and interferon inducing properties | |
| ATE159250T1 (de) | Neue pyrazinderivative, ihre herstellung und verwendung | |
| NO864147D0 (no) | Fremgangsmaate for fremstilling av alginater(polyuronider) med endrede fysikalske egenskaper. | |
| DE3867445D1 (de) | Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren. | |
| PT101007A (pt) | Preparado liofilizado e estavel de icrf-187 e seu uso e processo de preparacao de liofilizado de icrf-187 | |
| DE3767308D1 (de) | Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels. | |
| NO883520D0 (no) | Fremgangsmaate for fremstilling av et injeksjonspreparat. | |
| DK527186D0 (da) | Bronchodilaterende farmaceutisk praeparat | |
| KR840002657A (ko) | 인터페론 조성물의 제조방법 | |
| JPS646220A (en) | Stable freeze-dry herpes virus live vaccine | |
| 落合芳博 et al. | Isolation and characterization of myosin light chains from skipjack ordinary muscle. | |
| ATE135364T1 (de) | Wasserfreie kristalle von 4-carbamoyl-1-beta-d- ribofuranosyl-imidazolium-5-olat | |
| JPS55164630A (en) | Freeze-dried preparation of anti-hbs globulin | |
| NO301805B1 (no) | Fremgangsmåte for fremstilling av et stabilt, galenisk, vandig preparat av erytropoietin | |
| DE3880498D1 (de) | Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung. | |
| FR2425858A1 (fr) | Composition ophtalmique pour le traitement de la senescence cristallinienne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19930708 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19990420 |
|
| MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20140421 |